SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (197)5/23/2003 12:13:27 PM
From: JFitnich  Read Replies (1) of 590
 
I've seen 15% response rates from 2 different analysts. I don't know what they are basing that information on.

I'm hoping it's not "they continued to enroll the trial, the results must be positive...so it must be a Mid-teen response rate". I'm almost wishing against Reg FD, and hoping they got tipped off : )

From a stock standpoint, if the results released don't approach the 15% indicated, I think we could see the $7 or $8 range again come Monday.

ABGX is my 3rd biggest position, so I'm hoping for good results. I used the Kidney trial "failure" as a chance to build a larger position. Hopefully the AMGN/ABGX PR machine will not have a repeat of that situation.

JF
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext